MCOV-B 📈 Medicover AB (publ) - Overview

Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0009778848

MCOV-B: Healthcare services, Diagnostic services, Medical tests

Medicover AB (publ) operates as a comprehensive healthcare provider, offering a broad range of services across Poland, Sweden, and international markets. The company's healthcare services segment encompasses a diverse portfolio, including outpatient and inpatient care, dental services, and other non-medical related services such as sports memberships, benefit cards, and optics, in addition to wellness services. Furthermore, hospital care and preventive care are also integral components of their healthcare offerings, underscoring the company's commitment to delivering holistic care solutions. This multifaceted approach enables Medicover to cater to a wide range of needs, from routine check-ups to complex medical procedures.

The diagnostic services arm of Medicover AB (publ) is equally robust, featuring an extensive array of tests designed to facilitate accurate diagnoses and informed treatment decisions. These tests span various disciplines, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry, and immunochemistry, among others. The company's diagnostic capabilities also extend to blood group diagnostics, transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. This breadth of diagnostic services positions Medicover as a one-stop solution for patients and healthcare providers seeking comprehensive diagnostic support.

Medicover AB (publ) serves a diverse client base, comprising corporate entities, individuals, and public payers. This diversified approach allows the company to leverage its expertise and resources across different markets and customer segments, fostering growth and stability. Founded in 1995, Medicover has established a strong presence in the healthcare industry, with its headquarters located in Stockholm, Sweden. The company's web presence can be accessed at https://www.medicover.com, providing a gateway to its services, mission, and values. With its common stock listed under the ISIN SE0009778848 and classified under the GICS Sub Industry: Health Care Services, Medicover AB (publ) is poised for continued expansion and innovation in the healthcare sector.

Additional Sources for MCOV-B Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

MCOV-B Stock Overview

Market Cap in USD 2,424m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Services
IPO / Inception

MCOV-B Stock Ratings

Growth 5y 37.6%
Fundamental 16.3%
Dividend 49.1%
Rel. Strength Industry 1247
Analysts -
Fair Price Momentum 182.69 SEK
Fair Price DCF 43.11 SEK

MCOV-B Dividends

Dividend Yield 12m 0.06%
Yield on Cost 5y 0.11%
Annual Growth 5y 19.68%
Payout Consistency 98.8%

MCOV-B Growth Ratios

Growth Correlation 3m -29.9%
Growth Correlation 12m 48.7%
Growth Correlation 5y 26.5%
CAGR 5y 12.58%
CAGR/Mean DD 5y 0.35
Sharpe Ratio 12m 0.73
Alpha 5.76
Beta 0.89
Volatility 44.25%
Current Volume 48.1k
Average Volume 20d 42.5k
What is the price of MCOV-B stocks?
As of December 21, 2024, the stock is trading at SEK 192.40 with a total of 48,147 shares traded.
Over the past week, the price has changed by +2.36%, over one month by +10.14%, over three months by -1.95% and over the past year by +31.42%.
Is Medicover AB (publ) a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Medicover AB (publ) is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 16.26 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MCOV-B as of December 2024 is 182.69. This means that MCOV-B is currently overvalued and has a potential downside of -5.05%.
Is MCOV-B a buy, sell or hold?
Medicover AB (publ) has no consensus analysts rating.
What are the forecast for MCOV-B stock price target?
According to ValueRays Forecast Model, MCOV-B Medicover AB (publ) will be worth about 202.2 in December 2025. The stock is currently trading at 192.40. This means that the stock has a potential upside of +5.1%.
Issuer Forecast Upside
Wallstreet Target Price 223.5 16.1%
Analysts Target Price - -
ValueRay Target Price 202.2 5.1%